Yahoo! Finance: YMI News

Latest Financial News for YM BIOSCIENCES INC

• Notice of YM Biosciences Annual and Special Meeting of Shareholders (CNW Group)

  (Mon, 17 Nov 2008 21:02:00 Etc/GMT)

• Ym Biosciences Subsidiary Cimym Notifies Oncoscience Ag of Intention to Submit Issues for Arbitration (PR Newswire)

  (Mon, 17 Nov 2008 06:00:00 Etc/GMT)

  YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that CIMYM BioSciences Inc., a corporation owned by YM and CIMAB S.A., has notified Oncoscience AG, the licensee for its drug, nimotuzumab, that it intends to submit issues for arbitration to the London Court of International Arbitration .

• BBM Looks for Bargain in YM Biosciences Acquisition Proposal (at Seeking Alpha)

  (Sat, 15 Nov 2008 22:18:00 Etc/GMT)

• YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT (CNW Group)

  (Thu, 13 Nov 2008 18:49:00 Etc/GMT)

  YM BioSciences Inc. , an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that an unsolicited proposal has reportedly been made to acquire the Company at a price of approximately US$0.50 per share or approximately US$29 million.

• BBM Announces Offer to Acquire YM BioSciences Inc. (PR Newswire)

  (Thu, 13 Nov 2008 15:44:00 Etc/GMT)

  BBM Holdings announced today that it has made an offer to acquire YM BioSciences Inc. by a letter to YMI's Chief Executive Officer, Dr. David Allan.

• YM BIOSCIENCES REPORTS FIRST QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS (CNW Group)

  (Tue, 11 Nov 2008 23:00:00 Etc/GMT)

• YM BIOSCIENCES REPORTS DATA FROM EXPLORATORY CLINICAL TRIALS OF NIMOTUZUMAB IN BRAIN METASTASES AND HIGH-GRADE GLIOMA PRESENTED AT 2008 EORTC-NCI-AACR ANNUAL MEETING (CNW Group)

  (Mon, 3 Nov 2008 22:40:00 Etc/GMT)

• YM BIOSCIENCES INC Financials (EDGAR Online Financials)

  (Wed, 1 Oct 2008 13:04:13 Etc/GMT)

• YM BIOSCIENCES REPORTS DAIICHI AND KUHNIL ENROL FIRST PATIENTS IN RANDOMIZED PHASE II GASTRIC TRIAL (CNW Group)

  (Tue, 30 Sep 2008 21:00:00 Etc/GMT)

• YM BIOSCIENCES REPORTS FISCAL YEAR END 2008 OPERATIONAL AND FINANCIAL RESULTS (CNW Group)

  (Fri, 19 Sep 2008 21:50:00 Etc/GMT)

Yahoo! Finance: YMI Financial Blogs

Latest Financial Financial Blogs for YM BIOSCIENCES INC

• BBM Looks for Bargain in YM Biosciences Acquisition Proposal (at Seeking Alpha)

  (Sat, 15 Nov 2008 22:18:00 Etc/GMT)

MSN Money News - YMI

News about YM BioSciences Inc

• Market Report -- In Play (YMI)

  (Thursday, November 13, 2008 10:53 AM)

  YM BioSciences: BBM announces offer to acquire YM BioSciences for $0.50/share plus 0.375 share of BBM common stock BBM Holdings (OTC: BBMO) announces that it has made an offer to acquire YM

• BBM Announces Offer to Acquire YM BioSciences Inc

  (Thursday, November 13, 2008 10:44 AM)

  NEW YORK, Nov. 13 /PRNewswire-FirstCall/ -- BBM Holdings (OTC Bulletin Board: BBMO) announced today that it has made an offer to acquire YM BioSciences Inc. (Amex: YMI) by a letter to YMI's Chief

YMI - News and Analysis from Seeking Alpha

'YMI' Tag RSS Syndication from SeekingAlpha.com

• BBM Looks for Bargain in YM Biosciences Acquisition Proposal

  (Sat, 15 Nov 2008 17:18:00 -0500)

  Eben Tessari submits:

  Talk about a tough market, according to a recent report, half of all biotech’s with a market cap under $200M are trading for less than cash on hand. YM Biosciences (YMI)  is no exception and BBM is trying to snag a bargain.

  Under BBM’s proposal, BBM would acquire all of the outstanding shares of YMI common stock for consideration per share of $0.50 in cash plus 0.375 share of BBM common stock (aggregating for all YMI stockholders approximately 45% of the combined company’s outstanding stock after giving effect to the merger)....

• YM Biosciences' Trials Are Worth Watching

  (Thu, 21 Feb 2008 09:59:02 -0500)

  Speaking of busted biotechs - a subscriber to my paid service asked me to look at YM Biosciences (YMI), a Canadian cancer company trading for its cash, down from $6 to a buck and change. Is this a buy signal?

  Reflexively, many traders and speculators - as opposed to investors - are attracted to busted biotechs with lots of cash (at their current burn rate, YMI can last four years without new money), who need just one catalyst - an approval, new trial data something - to make the stock double.

  
  Complete Story »

• YM BioSciences: YMI Trading Below Cash?

  (Fri, 14 Dec 2007 04:21:16 -0500)

  Mike Havrilla submits:

  With shares of YM BioSciences (YMI) currently trading below $1.15 intraday, investors must be wondering why the Company is trading below its cash position of $1.25/share along with zero debt. A quick glance at YM Bio's financials reveals a net loss (ttm) of about $25 million on revenue (ttm) of $4.6 million and just under 56 million shares of common stock outstanding with an average trading volume of just under 150,000 shares per day and minimal short interest in the stock at just over 2 days worth of average volume to cover.

  The Company is making progress...

• The Ins and Outs of Terror-Free Investing

  (Thu, 12 Jul 2007 05:08:07 -0400)

  Richard Shaw (QVM Group) submits: ?Terror-free? investing is a relatively new form of investing that excludes from portfolios those companies that have identifiable business activities in countries that support terrorism.

  Just as the South Africa disinvestment movement decades ago caused companies to terminate operations there, the theory is that terror-free investing will cause companies to stop doing business in or with countries considered to be state sponsors of terror.

  The Missouri State Treasurer gave birth to the movement in June 2006 when she set up a terror-free investment fund within...

• Versant: YM Biosciences Now a 'Speculative Buy'

  (Tue, 10 Apr 2007 15:37:56 -0400)

  FP Trading Desk submits: Versant analyst Douglas Loe upgraded his recommendation on YM Biosciences Inc. (YMI) Tuesday, following a recent trip to Cuba, where YM's head and neck cancer treatment, the nimotuzumab antibody, is being developed.

  In a note to clients, Mr. Loe said he remains positive following visits to the Center of Generic Engineering and Biotechnology and the Center for Molecular Immunology in Havana, that nimotuzumab's potential to confer 'efficacy without rash' remains a key point of differentiation from other comparable cancer drugs such...

• Weekend Follies: Press Releases While Nobody's Looking

  (Mon, 17 Apr 2006 10:15:27 -0400)

  George Gutowski submits: Ten culprits this Good Friday Weekend. I try to catch companies issuing substantive news at odd-ball hours during the weekend.

  Two NYSE listings: Walmart (WMT) and AON Corp (AON).

  
  Complete Story »

Investor Clicks Financial Advertising

News for YM BioSciences Inc. (USA) - Google Finance

News for YM BioSciences Inc. (USA) - Google Finance

• Notice of YM Biosciences Annual and Special Meeting of Shareholders

  (Mon, 17 Nov 2008 21:13:54 GMT)
  Notice of YM Biosciences Annual and Special Meeting of Shareholders
  Stockhouse - Nov 17, 2008

  YM BioSciences Inc . ( NYSE Alternext US : YMI , TSX : YM , AIM : YMBA ) , an oncology company that identifies , develops and commercializes differentiated products for patients worldwide , will ...

• YM BIOSCIENCES SUBSIDIARY CIMYM NOTIFIES ONCOSCIENCE AG OF INTENTION TO SUBMIT ISSUES FOR ARBITRATION

  (Mon, 17 Nov 2008 06:08:46 GMT)
  YM BIOSCIENCES SUBSIDIARY CIMYM NOTIFIES ONCOSCIENCE AG OF INTENTION TO SUBMIT ISSUES FOR ARBITRATION
  MarketWatch - Nov 17, 2008

  MISSISSAUGA , ON , Nov 17 , 2008 / PRNewswire - FirstCall via COMTEX / - - YM BioSciences Inc . ( CA : YM : news , chart , profile ) , an oncology company that identifies , develops and commercializes ...

• YM Biosciences Responds To BBM Announcement

  (Fri, 14 Nov 2008 12:46:40 GMT)
  YM Biosciences Responds To BBM Announcement
  PharmaLive.com (press release) - Nov 14, 2008

  MISSISSAUGA , ON , Nov . 13 - YM BioSciences Inc . ( NYSE Alternext US : YMI , TSX : YM , AIM : YMBA ) , an oncology company that identifies , develops and commercializes differentiated products ...

• YM Biosciences responds to BBM Announcement

  (Fri, 14 Nov 2008 09:46:07 GMT)
  YM Biosciences responds to BBM Announcement
  PresseBox (Pressemitteilung) - Nov 14, 2008

  ( pressebox ) Mississauga , Ontario , 14.11 . 2008 - YM BioSciences Inc . ( NYSE Alternext US : YMI , TSX : YM , AIM : YMBA ) , an oncology company that identifies , develops and commercializes ...

• BBM Announces Offer to Acquire YM BioSciences Inc.

  (Fri, 14 Nov 2008 09:02:43 GMT)
  BBM Announces Offer to Acquire YM BioSciences Inc.
  PresseBox (Pressemitteilung) - Nov 14, 2008

  ( pressebox ) New York , 14.11 . 2008 - BBM Holdings ( OTC Bulletin Board : BBMO - News ) announced today that it has made an offer to acquire YM BioSciences Inc . ( Amex : YMI - News ) by a ...

• BBM Holdings Offers to Acquire YM Biosciences

  (Thu, 13 Nov 2008 19:55:59 GMT)
  BBM Holdings Offers to Acquire YM Biosciences
  TechFinance - Nov 13, 2008

  BBM Holdings , Inc . ( OTC BB : BBMO ) of Salt Lake City , Utah announced today that it has sent a letter offering to acquire to acquire YM BioSciences Inc . ( NYSE Alternext US : YMI ; TSX : ...

• YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT

  (Thu, 13 Nov 2008 19:01:28 GMT)
  YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT
  Canada NewsWire (press release) - Nov 13, 2008

  MISSISSAUGA , ON , Nov . 13 / CNW / - YM BioSciences Inc . ( NYSE Alternext US : YMI , TSX : YM , AIM : YMBA ) , an oncology company that identifies , develops and commercializes differentiated ...

• Market Report -- In Play (YMI)

  (Thu, 13 Nov 2008 16:18:55 GMT)
  Market Report -- In Play (YMI)
  MSN Money - Nov 13, 2008

  YM BioSciences : BBM announces offer to acquire YM BioSciences for $0.50 / share plus 0.375 share of BBM common stock BBM Holdings ( OTC : BBMO ) announces that it has made an offer to acquire ...

  BBM Announces Offer to Acquire YM BioSciences Inc. - MarketWatch
  

• YM Biosciences Reports First Quarter 2009 Operational And Financial Results

  (Wed, 12 Nov 2008 13:29:10 GMT)
  YM Biosciences Reports First Quarter 2009 Operational And Financial Results
  PharmaLive.com (press release) - Nov 12, 2008

  MISSISSAUGA , ON , Nov . 11 , 2008 / CNW / - YM BioSciences Inc . ( NYSE Alternext US : YMI , TSX : YM , AIM : YMBA ) , an oncology company that identifies , develops and commercializes differentiated ...

• YM BIOSCIENCES REPORTS FIRST QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

  (Tue, 11 Nov 2008 23:10:07 GMT)
  YM BIOSCIENCES REPORTS FIRST QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
  Canada NewsWire (press release) - Nov 11, 2008

  - looking statements , which reflect the Company's current expectation regarding future events.These forward - looking statements involve risks and uncertainties that may cause actual results ...

MarketWatch.com - All MarketWatch News - YMI

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products.

• Jon Friedman's Media Web: Thomson-Reuters won't roll over Bloomberg

  ()

  NEW YORK (MarketWatch) -- Thomson Corp. and Reuters Group, two of the most prestigious names in the news and information-gathering business, are planning to join forces. Naturally, there is lots of talk about synergies and cost savings.

Only registered users can write comments.
Please login or register.

---